Integer Holdings Non-GAAP EPS of $1.34 misses by $0.34, revenue of $449.66M misses by $7.49M (ITGR:NYSE)
Integer Holdings reported Q3 Non-GAAP EPS of $1.34, missing estimates by $0.34, and revenue of $449.66M, missing by $7.49M. Cardio & Vascular sales declined 5% year-over-year to $263M. According to the company, the results reflect previously communicated challenges.
How this was made
The 30-second read
Why it matters
The earnings miss could trigger a short‑term pullback, but upcoming pipeline news may provide upside potential.
Market read
First‑report earnings miss for a mid‑cap med‑tech stock; relevant for traders monitoring sector performance.
What to watch
Management hinted at upcoming product launches that could offset short‑term weakness.
Background
Integer Holdings is a US‑listed medical device company focused on cardiovascular and vascular products.
Ticker impact
Integer Holdings reported Q3 Non-GAAP EPS of $1.34, missing expectations by $0.34 and revenue of $449.66M, down 3.9% YoY.
likely downside as investors price in the EPS and revenue shortfall
Both EPS and revenue fell short of expectations, a typical catalyst for short-term price declines.
Market effects
May weigh on the medical device sector as Integer is a peer to other cardiovascular equipment makers.
Limited to US-listed med‑tech stocks; no broader regional effect.
Minimal global impact beyond sector peers.
Counterpoint
If the miss is already priced in, the stock could rebound on a short-cover rally.
Key entities
- CompanyInteger Holdings
US‑listed medical device manufacturer (ticker ITGR).
